Effects of antioxidant vitamins along with atorvastatin and atorvastatin-niacin combination on diet-induced hypercholesterolemia in rats

International Journal of Physiology, Pathophysiology and Pharmacology

Volumn 2, Issue 1, 2010, Pages 57-63

  Solanki, Yogendrasinh B ^a   Bhatt, Rajendra V ^a  

^a L M COLLEGE OF PHARMACY   (India)

Author keywords

Antioxidants; Atorvastatin; Hypercholesterolemia; Lipid peroxidation; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; ATORVASTATIN; BETA CAROTENE; CATALASE; CHOLESTEROL; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; NICOTINIC ACID; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HYPERCHOLESTEROLEMIA; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; LIVER; MALE; MONOTHERAPY; MORNING DOSAGE; NONHUMAN; OXIDATIVE STRESS; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 77953419988     PISSN: None     EISSN: 19448171     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC and Witztum JL. Beyond cholesterol: modification of low-density lipoprotein that increases it atherogenecity, N Engl J Med 1989; 320: 915-924.
2. Parathasarathy S, Santanam N and Auge N. Oxidized low density lipoprotein: a two faced janus in coronary artery disease? Biochem Pharmacol 1998; 56: 279-284.
3. Navab M, Berliner JA, Watson AD, Hama SY, Territo MC, Lusis AJ, Shih DM, Van Lentern BJ, Frank JS, Demer LL, Edwards PA and Foglemen AM. The yin and yang of oxidation in the development of the fatty streaks. New Engl J Med 1996; 16: 831-842.
4. Terpstra V, Bird DA and Steinberg D. Evidence that the lipid moiety of oxidized low density lipoprotein plays a role in its interaction with macrophage receptors, PNAS 1998; 95(4): 1806-1811.
5. Heinecke JW. Free radical modification of low density lipoprotein: mechanism and biological consequences. Free Rad Boil Med 1987; 3: 65-73.
6. Jargons G, Hhoff HF, Chisolm GM and Esterbauer H. Modification of human serum low-density lipoprotein by oxidation, characterization and pathophysiological implications. Chem Phys Lipids 1987; 45: 315-336.
7. Esterbauer H, Jargons G, Quehenberger O and Koller E. Auto-oxidation of human low-density lipoprotein: loss of polyunsaturated fatty acids and vitamin-E and generation of aldehydes. J Lip Res 1987; 28: 495-509.
8. Ramirez J and Flowers NC. Leukocyte ascorbic acid and its relationship to coronary heart disease in man. Am J Clin Nutr 1980; 33: 2079-2087.
9. Reimersma RA, Wood DA, Macintyre CCH, Elton RA, Gey KF and Oliver MF. Low plasma vitamin-E and C increased risk of angina in Scottish men. Ann NY Acad Sci 1989; 570: 291-295.
10. Gey KF, Moaer UK, Jordan P, Stahelin HB, Eichholzer M and Ludin E. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin-C. Am J Clin Nutr 1993; 57: 787s-797s.
11. Reaven PD, Khouw A, Beltz WF, Parathasarathy S and Witztum JL. Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin-E but not by beta-carotene. Arterioscler Thromb 1993; 13: 590-600.
12. Donaldson WE. Atherosclerosis in cholesterol fed Japanese quill: evidence for amelioration by dietary vitamin E. Poult Sci 1982; 61: 2097-2102.
13. Hodis HN, Mack EJ, LaBree L, Cashin-Hemphill L, Sevanian A, Johnson R and Azen SP. Serial coronary angiographic evidence that antioxidants vitamin intake reduces progression of coronary artery atherosclerosis. J Am Med Assoc 1995; 21: 1849-1854.
14. Stephens NG, Parson A, Shields PM, Kelly F, Cheesman K and Mitchinson, MJ. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidants study. Lancets 1996; 347: 781-786.
15. Gaziano JM, Hatta A, Flynn M, Johnson EJ, Krinsky NJ, Ridker PM, Hennekens CH and Frei B. Supplementation with beta-carotene in vivo and in vitro does not inhibit low-density lipoprotein oxidation. Atherosclerosis 1995; 112: 187-195.
16. Zhang SH, Reddick RL, Avdievich E, Surles LK, Jones RG, Reynolds JB, Quarfordt SH and Maeda N. Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E deficient mice. J Clin Invest 1997; 99: 2858-2865.
17. Cheung MC, Zhao X-Q, Chait A, Albers JJ and Brown BG. Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL. Arterioscler Thromb Vasc Biol 2001; 21: 1320-1326.
18. Committee for the Purpose of Supervision and Control of Experiments on Animals. CPCSEA guidelines for laboratory animal facility. Indian J Pharmacol 2003; 35: 257-272.
19. Blank B, Pfeiffer FR, Greenberg CM and Kerwin JF. Thyromimetics II: The synthesis and Hypocholesterolemic activity of some b-Dimethylaminoethyl esters of Iodinated Thyroalkanoic acids. J Med Chem 1963; 6: 560-563.
20. Friedwald WT, Levy RI and Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol without the use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
21. Lowry OH, Rosenbrough NJ, Farr AL and Randall RJ. Protein measurement with Folin Phenol reagent. J Bio Chem 1951; 193: 265-275.
22. Okhawa H, Ohisi N and Yagi, K. Assay of lipid peroxides in animal tissues by thiobarbituric reaction. Anal Biochem 1979; 95: 351-353.
23. Misra HP and Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Boil Chem 1972; 247: 3170-3175.
24. Aebi H. Catalase. Methods of Enzymatic Analysis. Edited by Bergmayer HU. New York and London, Academic Pres, 1974, pp. 673-677
25. Beutler E, Duron O and Kelly B. Reduced glutathione estimation. J Clin Med 1963; 61: 882-885.
26. Guyton JR and Capuzzi DM. Treatment of hyperlipidemia with combined niacin-statin regimens. Am J Cardiol 1998; 82: 82U-84U.
27. Takemoto M, Node K, Nakagami H, Liao Y, Grimm M, Takemoto Y, Kitakaze M and Liao JK. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest 2001; 108: 1429-1437.
28. rd, Mori TA and Puddey IB. Effects of vitamin C and vitamin E on in vivo lipid peroxidation: results of a randomized controlled trial. Am J Clin Nutr 2002; 76: 549-555.
29. Porkkala-Sarataho E, Salonen JT, Nyyssönen K, Kaikkonen J, Salonen R, Ristonmaa U, Diczfalusy U, Brigelius-Flohe R, Loft S and Poulsen HE. Long -Term Effects of Vitamin E, Vitamin C, and Combined Supplementation on Urinary 7-Hydro-8-Oxo-2′-Deoxyguanosine, Serum Cholesterol Oxidation Products, and Oxidation Resistance of Lipids in Nondepleted Men. Arterioscler Thromb Vasc Biol 2000; 20: 2087-2093.
30. Meister A. Glutathione-ascorbic acid antioxidant system in animals. J Bio Chem 1994; 269: 9397-9400.
31. McCord JM. Is superoxide dismutase a stress protein? Stress proteins in inflammation. Edited by Burbon R, Rice-Evans, Blake D and Winrow C. London, Richelieu Press, 1990, pp. 125-134
32. Edge R and Truscott TG. Pro-oxidant and antioxidant reaction mechanism of carotene and radical interaction with vitamin E and C. Nutrition 1997; 13: 992-998.